JUVAF (Juva Life) Notes Receivable: $0.00 Mil (As of Mar. 2023)


What is Juva Life Notes Receivable?

Juva Life JUVAF -90.00% Notes Receivable is $0.00 Mil as of Mar. 2023.

Juva Life's Notes Receivable for the quarter that ended in Mar. 2023 was $0.00 Mil.

Juva Life Notes Receivable Historical Data

* Premium members only.

The historical data trend for Juva Life's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Juva Life Notes Receivable Chart

Juva Life Annual Data
Trend Dec19 Dec20
Notes Receivable
0.00 0.00

Juva Life Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Mar22 Jun22 Sep22 Mar23
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Juva Life Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of $0.00 Mil mean?
Juva Life (JUVAF) has a Notes Receivable of $0.00 Mil as of Mar. 2023. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Juva Life and its competitors.
Is Juva Life's Notes Receivable too high?
Juva Life's current Notes Receivable is $0.00 Mil.
How does Juva Life's Notes Receivable compare to AVRW and UPC?
Juva Life's Notes Receivable of $0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Drug Manufacturers company?
A good Notes Receivable depends on the Drug Manufacturers industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Juva Life and its competitors. Juva Life's current Notes Receivable is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Juva Life stock overvalued right now?
Juva Life (JUVAF) has a current Notes Receivable of $0.00 Mil. The current Notes Receivable is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Juva Life (JUVAF), the current Notes Receivable is $0.00 Mil as of Mar. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Juva Life Business Description

Address 885 West Georgia Street, Suite 1400, Vancouver, BC, CAN, V6C 3E8
Juva Life Inc is a life science company with both pharmaceutical research and development and consumer facing operations in cannabis production and distribution.